Woillard JB - Search Results

1

Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation.

Ponthier L, Marquet P, Moes DJAR, Rostaing L, van Hoek B, Monchaud C, Labriffe M, Woillard JB. Ponthier L, et al. Among authors: woillard jb. Eur J Clin Pharmacol. 2023 Feb;79(2):311-319. doi: 10.1007/s00228-022-03445-5. Epub 2022 Dec 24. Eur J Clin Pharmacol. 2023. PMID: 36564549

2

Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimus.

Maruani A, Moineau AG, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengelle C, Woillard JB, Herbreteau D, Le Touze A, Binet A, Morel B, Bourgoin H, Gissot V, Giraudeau B, Gruel Y, Tavernier E, Rollin J. Maruani A, et al. Among authors: woillard jb. Br J Dermatol. 2023 Jan 23;188(1):152-154. doi: 10.1093/bjd/ljac028. Br J Dermatol. 2023. PMID: 36689523 Free article. No abstract available.

3

Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?

Chatti I, Creveaux I, Woillard JB, Langlais S, Amara A, Ben Fatma L, Saad A, Gribaa M, Libert F. Chatti I, et al. Among authors: woillard jb. Therapie. 2016 Oct;71(5):507-513. doi: 10.1016/j.therap.2016.04.004. Epub 2016 May 18. Therapie. 2016. PMID: 27288213

4

Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment.

Chatti I, Woillard JB, Mili A, Creveaux I, Ben Charfeddine I, Feki J, Langlais S, Ben Fatma L, Saad A, Gribaa M, Libert F. Chatti I, et al. Among authors: woillard jb. Iran J Public Health. 2017 Dec;46(12):1704-1711. Iran J Public Health. 2017. PMID: 29259946 Free PMC article.

5

Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.

Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B. Maruani A, et al. Among authors: woillard jb. JAMA Dermatol. 2021 Nov 1;157(11):1289-1298. doi: 10.1001/jamadermatol.2021.3459. JAMA Dermatol. 2021. PMID: 34524406 Free PMC article. Clinical Trial.

6

High Throughput Proteomic Exploration of Hypothermic Preservation Reveals Active Processes within the Cell Associated with Cold Ischemia Kinetic.

Pasini-Chabot O, Vincent J, Le Pape S, Lepoittevin M, Kaaki W, Woillard JB, Giraud S, Bourmeyster N, Hauet T, Thuillier R. Pasini-Chabot O, et al. Among authors: woillard jb. Int J Mol Sci. 2021 Feb 27;22(5):2384. doi: 10.3390/ijms22052384. Int J Mol Sci. 2021. PMID: 33673561 Free PMC article.

7

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

Woillard JB, Rerolle JP, Picard N, Rousseau A, Drouet M, Munteanu E, Essig M, Marquet P, Le Meur Y. Woillard JB, et al. Br J Clin Pharmacol. 2010 Jun;69(6):675-83. doi: 10.1111/j.1365-2125.2010.03625.x. Br J Clin Pharmacol. 2010. PMID: 20565459 Free PMC article.

8

Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.

Gensburger O, Van Schaik RH, Picard N, Le Meur Y, Rousseau A, Woillard JB, Van Gelder T, Marquet P. Gensburger O, et al. Among authors: woillard jb. Pharmacogenet Genomics. 2010 Sep;20(9):537-43. doi: 10.1097/FPC.0b013e32833d8cf5. Pharmacogenet Genomics. 2010. PMID: 20679962 Free PMC article.

9

Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.

Benkali K, Rostaing L, Premaud A, Woillard JB, Saint-Marcoux F, Urien S, Kamar N, Marquet P, Rousseau A. Benkali K, et al. Among authors: woillard jb. Clin Pharmacokinet. 2010 Oct;49(10):683-92. doi: 10.2165/11535950-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20818834

10

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.

Woillard JB, de Winter BC, Kamar N, Marquet P, Rostaing L, Rousseau A. Woillard JB, et al. Br J Clin Pharmacol. 2011 Mar;71(3):391-402. doi: 10.1111/j.1365-2125.2010.03837.x. Br J Clin Pharmacol. 2011. PMID: 21284698 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters